Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Bayer plc, 400 South Oak Way, Reading RG2 6AD
Avelox 400 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Dull red film-coated tablet with an oblong, convex shape with facet, a dimension of 17 × 7 mm, and marked with “M400” on one side and “BAYER” on the other side. |
1 film-coated tablet contains 400 mg moxifloxacin (as hydrochloride).
Excipient with known effect: The film-coated tablet contains 68mg lactose monohydrate (=66.56 mg lactose) (see section 4.4).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Moxifloxacin |
Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair. |
| List of Excipients |
|---|
|
Tablet core: Microcrystalline cellulose Film-coat: Hypromellose |
Cartons containing colourless transparent or white opaque polypropylene/aluminium blisters or colourless transparent polyvinyl chloride/polyvinylidene chloride/aluminium blisters:
The film-coated tablets are available in packs of 5, 7, and 10 tablets, in hospital packs containing 25 (5 × 5), 50 (5 × 10), 70 (7 × 10) film-coated tablets or in hospital multipacks containing 80 (5 packs of 16) or 100 (10 packs of 10) film-coated tablets.
Cartons containing aluminium/aluminium blisters are available in packs of one film-coated tablet.
Not all pack sizes may be marketed.
Bayer plc, 400 South Oak Way, Reading RG2 6AD
PL 00010/0291
13 March 2003/12 February 2010
| Drug | Countries | |
|---|---|---|
| AVELOX | Austria, Cyprus, Ecuador, Estonia, Finland, Hong Kong, Ireland, Japan, Lithuania, Malta, Mexico, Nigeria, New Zealand, Romania, Singapore, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
